グローバルな製薬業:倫理、市場、実相<br>Global Pharmaceuticals : Ethics, Markets, Practices

個数:
  • ポイントキャンペーン

グローバルな製薬業:倫理、市場、実相
Global Pharmaceuticals : Ethics, Markets, Practices

  • ウェブストア価格 ¥7,627(本体¥6,934)
  • Duke University Press(2006/03発売)
  • 外貨定価 US$ 34.95
  • 【ウェブストア限定】ブラックフライデーポイント5倍対象商品(~11/24)※店舗受取は対象外
  • ポイント 345pt
  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 277 p.
  • 言語 ENG
  • 商品コード 9780822337416
  • DDC分類 338.476151

Full Description

In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. They demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from preclinical research to human testing, marketing, distribution, prescription, and consumption.Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/AIDS prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals. Some essays show how individual and communal identities are affected by the marketing and availability of medications. Among these are an exploration of how the pharmaceutical industry shapes popular and expert understandings of mental illness in North America and Great Britain. There is also an examination of the agonizing choices facing Ugandan families trying to finance AIDS treatment. Several essays explore the inner workings of the emerging international pharmaceutical regime. One looks at the expanding quest for clinical research subjects; another at the entwining of science and business interests in the Argentine market for psychotropic medications. By bringing the moral calculations involved in the production and distribution of pharmaceuticals into stark relief, this collection charts urgent new territory for social scientific research.

Contributors. Kalman Applbaum, JoÃo Biehl, Ranendra K. Das, Veena Das, David Healy, Arthur Kleinman, Betty Kyaddondo, Andrew Lakoff, Anne Lovell, Lotte Meinert, Adriana Petryna, Michael A. Whyte, Susan Reynolds Whyte

Contents

Acknowledgments vii
The Pharmaceutical Nexus / Adriana Petryna and Arthur Kleinman 1
Globalizing Human Subjects Research / Adriana Petryna 33
The New Medical Oikumene / David Healy 61
Educating for Global Mental Health: The Adoption of SSRIs in Japan / Kalman Applbaum 85
High Contact: Gifts and Surveillance in Argentina / Andrew Lakoff 111
Addiction Markets: The Case of High-Dose Buprenorphine in France / Anne M. Lovell 136
Pharmaceuticals in Urban Ecologies: The Register of the Local / Veena Das and Ranendra K. Das 171
Pharmaceutical Governance / JoÃo Biehl 206
Treating AIDS: Dilemmas of Unequal Access in Uganda / Susan Reynolds Whyte, Michael A. Whyte, Lotte Meinert, and Betty Kyaddondo 240
References 263
Contributors 289
Index 291

最近チェックした商品